Stocks
Intellia Therapeutics (NTLA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -100.8 | -130.3 | -261.0 | -450.6 | -506.3 | -527.5 | ||
| Changes by years, y/y, % | +11% | +29% | +100% | +73% | +12% | +41.0% | |||
Intellia Therapeutics. EBITDA US GAAP, bln rub
Intellia Therapeutics. EBITDA US GAAP, changes, %
Intellia Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Intellia Therapeutics (NTLA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -128.8 | -137.4 | -111.5 | -136.4 | -142.2 | -527.5 | |
| Changes by years, y/y, % | +35% | +31% | 0% | +3% | +10% | |||
| Changes by quarters, q/q, % | -3% | +7% | -19% | +22% | +4% | |||
